Merck's Keytruda fails late-stage study in liver cancer patients

  • 📰 Reuters
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 97%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

Merck & Co Inc's cancer drug Keytruda failed a late-stage trial's main...

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Merck & Co Inc's cancer drug Keytruda failed a late-stage trial's main goals of slowing disease progression and extending the life of patients with a common type of liver cancer, the company said on Tuesday.

DuncanGarnerNZ some information for you

Here is the Complaint filed today against The Washington Post on behalf of Nick Sandmann. All members of the mainstream & social media mob of bullies who recklessly & viciously attacked Nick would be well-served to read it carefully.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 2. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Merck to further study Keytruda in prostate cancer after early successMerck & Co Inc said on Thursday it was launching three late-stage studies for it...
Source: Reuters - 🏆 2. / 97 Read more »

Merck, Pfizer drug combo extends kidney cancer survival: studyA combination of Merck & Co's immunotherapy Keytruda and Pfizer Inc's ... Never trust a corporate shaman? says only “extends” survival compared to previous treatment.. doesn’t say how it or both compare to no medication
Source: Reuters - 🏆 2. / 97 Read more »

Merck to further study Keytruda in prostate cancer after early successMerck & Co Inc said on Thursday it was launching three late-stage studies for it...
Source: Reuters - 🏆 2. / 97 Read more »

Merck, Pfizer drug combo extends kidney cancer survival: studyA combination of Merck & Co's immunotherapy Keytruda and Pfizer Inc's ... Never trust a corporate shaman? says only “extends” survival compared to previous treatment.. doesn’t say how it or both compare to no medication
Source: Reuters - 🏆 2. / 97 Read more »

All breast cancer patients should get genetic testing, surgeons sayGenetic testing should be made available for all patients diagnosed with breast cancer, according to new guidelines from the American Society of Breast Surgeons Genetics are a social construct. Made available = have the patients pay for gebeticbtesting despite the immaturity of the nature regarding such tests (it's not an exact science) Genetic testing should be made available for all patients diagnosed with cancer* Fixed.
Source: CNN - 🏆 4. / 95 Read more »

Breast surgeons say all breast cancer patients should be offered genetic testingCurrent guidelines are too restrictive and may be missing people with mutations that could affect prevention and treatment, the surgeons group says. maggieNYT 25 years ago it genetic testing cost $2500 out of pocket. every employee at wapoop should undergo genetic testing Agree!
Source: washingtonpost - 🏆 95. / 72 Read more »

Racial disparities in US cancer deaths are shrinking, study findsHistorical disparities between black and white cancer patients in the United States are receding, a new study finds. Among men, the overall cancer death rate was 47% higher for blacks than for whites in 1990, but that difference dropped to 19% in 2016, and the disparity has been nearly eliminated in men younger than 50. Healthy lifestyle is expensive but justified in savings on healthcare. ValentinesDay Valentines ThursdayThoughts Cancer is so racist. CNN even race-baits cancer patients.
Source: CNN - 🏆 4. / 95 Read more »

Immunotherapies could change kidney cancer care, studies suggestTwo studies showed that renal cell cancer patients had significantly better outcomes when their treatment combined the targeted therapy drug axitinib, or Inlyta, with an immunotherapy -- one study used pembrolizumab, or Keytruda, and the other used avelumab, or Bavencio. Please follow me Y'all please go to Jussie Smollette's twitter page. The guy is promoting his debut album dropping March 2nd ,is this what they mean by alternate universe.
Source: CNN - 🏆 4. / 95 Read more »